319 related articles for article (PubMed ID: 34649482)
1. Application of expanded noninvasive prenatal test in prenatal diagnosis of fetuses with increased nuchal translucency.
Xie X; Zhou H; Zhao Q; Lu Y; Meng Y
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6213-6218. PubMed ID: 34649482
[TBL] [Abstract][Full Text] [Related]
2. Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data.
Zhang B; Zhang LX; Yi J; Wang CH; Zhao Y
Arch Gynecol Obstet; 2024 Apr; ():. PubMed ID: 38625542
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic yield of copy number variation sequencing in fetuses with increased nuchal translucency: a retrospective study.
Yang X; Bian X; Shi X; Ding J; Tang H; Xu P; Deng D; Zeng W; Chen S; Qiao F; Feng L; Wu Y
Arch Gynecol Obstet; 2024 Jan; 309(1):139-144. PubMed ID: 36602560
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency.
Wang C; Tang J; Tong K; Huang D; Tu H; Zhu J
J Hum Genet; 2022 Sep; 67(9):533-539. PubMed ID: 35578003
[TBL] [Abstract][Full Text] [Related]
6. Does isolated nuchal translucency from 2.5 to 2.9 mm increase the risk of fetal chromosome disease?
Yin D; Chen L; Wang L; Zeng Y; Tang F; Wang J
Mol Genet Genomics; 2022 Nov; 297(6):1643-1648. PubMed ID: 36056230
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency].
Du L; Xie HN; Zheng J; He M
Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):671-676. PubMed ID: 30369122
[No Abstract] [Full Text] [Related]
8. [Comparison of results of prenatal diagnosis by different techniques for fetuses with increased nuchal translucency].
Dai W; Liu X; Ma X; Yu Z; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 May; 40(5):532-537. PubMed ID: 37102284
[TBL] [Abstract][Full Text] [Related]
9. Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening.
Lan L; Wu H; She L; Zhang B; He Y; Luo D; Wang H; Zheng Z
J Clin Lab Anal; 2020 Aug; 34(8):e23347. PubMed ID: 32342531
[TBL] [Abstract][Full Text] [Related]
10. Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review.
Petersen OB; Smith E; Van Opstal D; Polak M; Knapen MFCM; Diderich KEM; Bilardo CM; Arends LR; Vogel I; Srebniak MI
Acta Obstet Gynecol Scand; 2020 Jun; 99(6):765-774. PubMed ID: 32306377
[TBL] [Abstract][Full Text] [Related]
11. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
[TBL] [Abstract][Full Text] [Related]
12. [Application of genomic copy number variation detection technology in prenatal diagnosis of 7617 pregnant women with serological screening abnormalities during the second trimester of pregnancy].
Huang J; Wu D; Gao Y; Li Q; Zhang C; He J; Li X; Wang H; Guo Q; Lou G; Wang Y; Liu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):468-473. PubMed ID: 35598259
[TBL] [Abstract][Full Text] [Related]
13. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
Huang LY; Pan M; Han J; Zhen L; Yang X; Li DZ
J Obstet Gynaecol; 2018 May; 38(4):498-501. PubMed ID: 29433355
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication.
Tian W; Yuan Y; Yuan E; Zhang L; Liu L; Li Y; Guo J; Cui X; Li P; Cui S
Eur J Med Res; 2023 Aug; 28(1):304. PubMed ID: 37644576
[TBL] [Abstract][Full Text] [Related]
15. [Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency].
Ni M; Li J; Zhu X; Zhu Y; Gu L; Wu X; Yang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):970-974. PubMed ID: 31598938
[TBL] [Abstract][Full Text] [Related]
16. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of expanded noninvasive prenatal testing in the detection of fetal subchromosomal microdeletion and microduplication in a cohort of 31,256 single pregnancies.
Xue H; Yu A; Lin M; Chen X; Guo Q; Xu L; Huang H
Sci Rep; 2022 Nov; 12(1):19750. PubMed ID: 36396840
[TBL] [Abstract][Full Text] [Related]
18. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
[TBL] [Abstract][Full Text] [Related]
19. A Chinese multicenter retrospective study of isolated increased nuchal translucency associated chromosome anomaly and prenatal diagnostic suggestions.
Jin H; Wang J; Zhang G; Jiao H; Zhu J; Li Z; Chen C; Zhang X; Huang H; Wang J
Sci Rep; 2021 Mar; 11(1):5596. PubMed ID: 33692422
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the results of non-invasive prenatal testing (NIPT) in 545 pregnant women in advanced maternal age.
Su JY; Wei YN; Chen HF; Tong JR; Chen Y; Deng L; Huang LL; Zhang LY
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7101-7106. PubMed ID: 37606120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
